Atrial Fibrillation: A Review of Recent Studies with a Focus on Those from the Duke Clinical Research Institute

by Meena P. Rao, Sean D. Pokorney, Christopher B. Granger
Published 2014-01-01

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas

by Christopher B Granger, Tymon Pol, Johan Lindbäck, M Cecilia Bahit, JW Eikelboom, Renato Lopes
Published 2021-06-01

Improvement in Care and Outcomes for Emergency Medical Service–Transported Patients With ST‐Elevation Myocardial Infarction (STEMI) With and Without Prehospital Cardiac Arrest: A M...

by Kristian Kragholm, Di Lu, Karen Chiswell, Hussein R. Al‐Khalidi, Mayme L. Roettig, Matthew Roe, James Jollis, Christopher B. Granger
Published 2017-10-01

Novel Biomarkers, ST‐Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention

by Jay S. Shavadia, Christopher B. Granger, Wendimagegn Alemayehu, Cynthia M. Westerhout, Thomas J. Povsic, Sean Van Diepen, Christopher Defilippi, Paul W. Armstrong
Published 2020-07-01

4031 Heart Transplant Candidates Listed at Low First-Offer Organ Acceptance Rate Centers are More Likely to Die Waiting

by Ashley Y Choi, Michael S. Mulvihill, Hui-Jie Lee, Congwen Zhao, Maragatha Kuchibhatla, Jacob N. Schroder, Chetan B. Patel, Christopher B. Granger, Matthew G. Hartwig
Published 2020-06-01

Factors influencing support for the implementation of community-based out-of-hospital cardiac arrest interventions in high- and low-performing counties

by Natalie Ezem, Allison A. Lewinski, Julie Miller, Heather A King, Megan Oakes, Lisa Monk, Monique A. Starks, Christopher B. Granger, Hayden B. Bosworth, Audrey L. Blewer
Published 2024-03-01

Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights F...

by Konstantinos I. Gkarmiris, Johan Lindbäck, John H. Alexander, Christopher B. Granger, Peter Kastner, Renato D. Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Published 2024-04-01

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events

by Sofia Attelind, Pär Hallberg, Mia Wadelius, Anna-Karin Hamberg, Agneta Siegbahn, Agneta Siegbahn, Christopher B. Granger, Renato D. Lopes, John H. Alexander, Lars Wallentin, Lars Wallentin, Niclas Eriksson
Published 2022-09-01

Health-related quality of life 1–3 years post-myocardial infarction: its impact on prognosis

by Christopher B Granger, David B Brieger, Karolina Andersson Sundell, Jiyan Chen, Dirk Westermann, Richard Grieve, Stuart Pocock, Mauricio G Cohen, Shaun Goodman, José C Nicolau, Katarina Hedman, Carl Mellström
Published 2021-06-01

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial

by Peter T. Hu, Renato D. Lopes, Susanna R. Stevens, Lars Wallentin, Laine Thomas, John H. Alexander, Michael Hanna, Basil S. Lewis, Freek W. A. Verheugt, Christopher B. Granger, W. Schuyler Jones
Published 2017-01-01

Association Between Driving Distance From Nearest Fire Station and  Survival of Out‐of‐Hospital Cardiac Arrest

by Steen M. Hansen, Carolina Malta Hansen, Christopher B. Fordyce, Matthew E. Dupre, Lisa Monk, Clark Tyson, Christian Torp‐Pedersen, Bryan McNally, Kimberly Vellano, James Jollis, Christopher B. Granger
Published 2018-11-01

Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation

by Ziad Hijazi, Christopher B. Granger, Stefan H. Hohnloser, Johan Westerbergh, Johan Lindbäck, John H. Alexander, Matyas Keltai, Alexander Parkhomenko, José L. López-Sendón, Renato D. Lopes, Agneta Siegbahn, Lars Wallentin
Published 2020-09-01

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

by Mika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic, Claes Held, Dimple Kauhanen, Antti Jylhä, Johan Lindbäck, Agneta Siegbahn, Christopher B. Granger, Wolfgang Koenig, Ralph A. H. Stewart, Harvey White, Reijo Laaksonen
Published 2020-05-01

Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis

by Christopher B Granger, Arno W Hoes, Frans H Rutten, Rosanne van Maanen, Geert-Jan Geersing, Linda P T Joosten, Sander van Doorn, Martin E W Hemels, Carline J van den Dries
Published 2023-02-01

Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Fai...

by Marat Fudim, Daniel M. Wojdyla, John H. Alexander, Shaun G. Goodman, Roxana Mehran, Stephan Windecker, Ronald Aronson, Dragos Vinereanu, Sigrun Halvorsen, M. Cecilia Bahit, Christopher B. Granger, Renato D. Lopes
Published 2021-12-01

Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease.

by Peter R Sinnaeve, Mark P Donahue, Peter Grass, David Seo, Jacky Vonderscher, Salah-Dine Chibout, William E Kraus, Michael Sketch, Charlotte Nelson, Geoffrey S Ginsburg, Pascal J Goldschmidt-Clermont, Christopher B Granger
Published 2009-09-01

Reducing system delays in treatment of ST elevation myocardial infarction and confronting the challenges of late presentation in low and middle-income countries

by Sameer Mehta, Christopher B. Granger, Timothy D. Henry, Cindy Lee Grines, Alexandra Lansky, Ivan Rokos, Roberto Botelho, Andreas Baumbach, Sundeep Mishra, Tan Huay Cheem, Damras Tresukosol, Robaayah Zambahari, Alexandra Ferré, Marco Castillo
Published 2017-04-01

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation

by Ziad Hijazi, Lars Wallentin, Johan Lindbäck, John H. Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher B. Granger, Renato D. Lopes, Tymon Pol, Salim Yusuf, Jonas Oldgren, Agneta Siegbahn
Published 2020-12-01

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction i...

by Tymon Pol, Claes Held, Johan Westerbergh, Johan Lindbäck, John H. Alexander, Marco Alings, Cetin Erol, Shinya Goto, Sigrun Halvorsen, Kurt Huber, Michael Hanna, Renato D. Lopes, Witold Ruzyllo, Christopher B. Granger, Ziad Hijazi
Published 2018-02-01

Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial

by John H Alexander, Christopher B Granger, Sigrun Halvorsen, Stephan Windecker, Dragos Vinereanu, Daniel M Wojdyla, Roxana Mehran, Shaun Goodman, Renato Lopes, Robert C. Welsh, Payam Dehghani, Ronald Aronson, Amit N Vora, Alexander Parkhomenko
Published 2022-02-01